Inventor · disambiguated record
Xing Wang
Also filed as: WANG XING · WANG XING HUA
25 granted patents·17 pending applications·200 citations·filing 2004–2022
96Inventor score
Top patents by PatentIndex Score
42 records- 0195US8501758B2Compounds and compositions as protein kinase inhibitorsHUANG SHENLIN·Filed 2010·Granted Aug 6, 2013·40 cites·12 claims
- 0292US9850230B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·7 cites·9 claims
- 0392US9593100B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·25 claims
- 0492US9593099B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·2 claims
- 0591US9850229B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·5 cites·20 claims
- 0691US8202876B2Compounds and compositions as protein kinase inhibitorsALBAUGH PAMELA·Filed 2007·Granted Jun 19, 2012·39 cites·9 claims
- 0789US9580426B2Compounds that expand hematopoietic stem cellsBOITANO ANTHONY E·Filed 2013·Granted Feb 28, 2017·13 cites·20 claims
- 0889US9314464B2Compounds and compositions as protein kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Apr 19, 2016·7 cites·27 claims
- 0988US8927281B2Method for expanding hematopoietic stem cellsBOITANO ANTHONY E·Filed 2009·Granted Jan 6, 2015·11 cites·22 claims
- 1087US10005761B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 26, 2018·3 cites·28 claims
- 1187US8431607B2Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2007·Granted Apr 30, 2013·12 cites·8 claims
- 1286US10787480B2Cytotoxic peptides and conjugates thereofNOVARTIS AG·Filed 2019·Granted Sep 29, 2020·2 cites·11 claims
- 1386US7868018B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2006·Granted Jan 11, 2011·11 cites·10 claims
- 1484US10973826B2Antibody conjugates comprising toll-like receptor agonistCORTEZ ALEX·Filed 2016·Granted Apr 13, 2021·6 cites·28 claims
- 1582US10392421B2Cytotoxic peptides and conjugates thereofNOVARTIS AG·Filed 2018·Granted Aug 27, 2019·3 cites·12 claims
- 1682US2023116233A1Compounds And Compositions As Protein Kinase InhibitorsARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1781US10576080B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Mar 3, 2020·1 cites·22 claims
- 1881US10568884B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 25, 2020·1 cites·14 claims
- 1981US9884817B2Auristatin derivatives and conjugates thereofGEIERSTANGER BERNHARD HUBERT·Filed 2015·Granted Feb 6, 2018·4 cites·17 claims
- 2080USRE49556ECompounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Granted Jun 20, 2023·0 cites·15 claims
- 2180US7449582B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Nov 11, 2008·15 cites·5 claims
- 2278US9988420B2Cytotoxic peptides and conjugates thereofGEIERSTANGER BERNHARD HUBERT·Filed 2014·Granted Jun 5, 2018·4 cites·29 claims
- 2375US8026243B2[4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitorsNOVARTIS AG·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 2473US2020323852A1Compounds And Compositions As Protein Kinase InhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2570US2021187033A1Compounds that expand hematopoietic stem cellsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2662US2021346387A1Antibody conjugates comprising toll-like receptor agonistNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2756US2017239296A1Compounds that expand hematopoietic stem cellsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2853US2021161957A1Nk cells and antibodies for cancer treatmentUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 2949US10280139B2Cytotoxic peptides and conjugates thereofNOVARTIS AG·Filed 2017·Granted May 7, 2019·0 cites·20 claims
- 3049US2010184765A1Protein Kinase Inhibitors and Methods for Using ThereofIRM LLC·Filed 2008·Application pending·0 cites
- 3148US2011053932A1Protein Kinase Inhibitors and Methods for Using ThereofIRM LLC·Filed 2008·Application pending·0 cites
- 3248US2013210769A1Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2013·Application pending·0 cites
- 3346US2009312321A1Compositions and methods for fgf receptor kinases inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 3445US2018153938A1NK Cells and Antibodies for Cancer TreatmentUNIV HEALTH NETWORK·Filed 2015·Application pending·0 cites
- 3544US7750032B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2006·Granted Jul 6, 2010·0 cites·9 claims
- 3641US2008292608A1Compounds and Compositions as Ppar ModulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 3741US2009192203A1Compounds and compositions as ppar modulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 3841US2020164084A1Antibody conjugates comprising toll-like receptor agonist and combination therapiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 3939US9181238B2N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitorsPAN SHIFENG·Filed 2011·Granted Nov 10, 2015·0 cites·11 claims
- 4039US2019194315A1Antibody drug conjugatesABRAMS TINYA·Filed 2016·Application pending·0 cites
- 4138US2007244130A1Compounds and Compositions as Ppar ModulatorsIRM LLC·Filed 2005·Application pending·0 cites
- 4238US2007203155A1Compounds And Compositions As Ppar ModulatorsIRM LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xing Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →